These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 26695758)
21. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels. Blick G Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769 [TBL] [Abstract][Full Text] [Related]
22. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. Leder BZ; Finkelstein JS Osteoporos Int; 2005 Dec; 16(12):1487-94. PubMed ID: 15856361 [TBL] [Abstract][Full Text] [Related]
23. EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM. Cunningham G; Belkoff L; Brock G; Efros M; Gittelman M; Carrara D; Neijber A; Ando M; Mitchel J Endocr Pract; 2017 May; 23(5):557-565. PubMed ID: 28225313 [TBL] [Abstract][Full Text] [Related]
24. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism. Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499 [TBL] [Abstract][Full Text] [Related]
25. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men. Behre HM; Heinemann L; Morales A; Pexman-Fieth C Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063 [TBL] [Abstract][Full Text] [Related]
26. Testosterone nasal gel (Natesto) for hypogonadism. Med Lett Drugs Ther; 2015 May; 57(1468):73-4. PubMed ID: 25941957 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, Clinical Efficacy, Safety Profile, and Patient-Reported Outcomes in Patients Receiving Subcutaneous Testosterone Pellets 900 mg for Treatment of Symptoms Associated With Androgen Deficiency. McMahon CG; Shusterman N; Cohen B J Sex Med; 2017 Jul; 14(7):883-890. PubMed ID: 28673432 [TBL] [Abstract][Full Text] [Related]
28. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study. Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic characteristics, efficacy, and safety of buccal testosterone in hypogonadal males: a pilot study. Dobs AS; Hoover DR; Chen MC; Allen R J Clin Endocrinol Metab; 1998 Jan; 83(1):33-9. PubMed ID: 9435413 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the steady-state pharmacokinetics, metabolism, and variability of a transdermal testosterone patch versus a transdermal testosterone gel in hypogonadal men. Mazer N; Bell D; Wu J; Fischer J; Cosgrove M; Eilers B; J Sex Med; 2005 Mar; 2(2):213-26. PubMed ID: 16422889 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study. Salehian B; Wang C; Alexander G; Davidson T; McDonald V; Berman N; Dudley RE; Ziel F; Swerdloff RS J Clin Endocrinol Metab; 1995 Dec; 80(12):3567-75. PubMed ID: 8530600 [TBL] [Abstract][Full Text] [Related]
32. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men. Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ J Androl; 1998; 19(6):761-8. PubMed ID: 9876028 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome. Aversa A; Bruzziches R; Francomano D; Spera G; Lenzi A J Endocrinol Invest; 2010 Dec; 33(11):776-83. PubMed ID: 20220293 [TBL] [Abstract][Full Text] [Related]
34. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel. Swerdloff RS; Wang C Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501 [TBL] [Abstract][Full Text] [Related]
35. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up. Behre HM; Tammela TL; Arver S; Tolrá JR; Bonifacio V; Lamche M; Kelly J; Hiemeyer F; ; Giltay EJ; Gooren LJ Aging Male; 2012 Dec; 15(4):198-207. PubMed ID: 22834649 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and drying time of testosterone 2% gel in men with hypogonadism: a multicenter, open-label, single-arm trial. Morgentaler A; McGettigan J; Xiang Q; Danoff TM; Gould EM Int J Impot Res; 2015; 27(2):41-5. PubMed ID: 25056809 [TBL] [Abstract][Full Text] [Related]
37. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men. Meikle AW; Mazer NA; Moellmer JF; Stringham JD; Tolman KG; Sanders SW; Odell WD J Clin Endocrinol Metab; 1992 Mar; 74(3):623-8. PubMed ID: 1740497 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men. Singh AB; Norris K; Modi N; Sinha-Hikim I; Shen R; Davidson T; Bhasin S J Clin Endocrinol Metab; 2001 Jun; 86(6):2437-45. PubMed ID: 11397836 [TBL] [Abstract][Full Text] [Related]
39. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function. Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639 [TBL] [Abstract][Full Text] [Related]
40. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. Shabsigh R; Kaufman JM; Steidle C; Padma-Nathan H J Urol; 2004 Aug; 172(2):658-63. PubMed ID: 15247755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]